Annual Net Income
-$10.42 M
+$2.80 M+21.21%
December 1, 2023
Summary
- As of February 7, 2025, BRTX annual net profit is -$10.42 million, with the most recent change of +$2.80 million (+21.21%) on December 1, 2023.
- During the last 3 years, BRTX annual net income has risen by +$855.00 thousand (+7.58%).
- BRTX annual net income is now -360.19% below its all-time high of -$2.26 million, reached on December 31, 2010.
Performance
BRTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$1.09 M
+$2.94 M+72.91%
September 1, 2024
Summary
- As of February 7, 2025, BRTX quarterly net profit is -$1.09 million, with the most recent change of +$2.94 million (+72.91%) on September 1, 2024.
- Over the past year, BRTX quarterly net income has dropped by -$5.86 million (-122.89%).
- BRTX quarterly net income is now -122.89% below its all-time high of $4.77 million, reached on September 1, 2023.
Performance
BRTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$9.65 M
-$5.86 M-154.71%
September 1, 2024
Summary
- As of February 7, 2025, BRTX TTM net profit is -$9.65 million, with the most recent change of -$5.86 million (-154.71%) on September 1, 2024.
- Over the past year, BRTX TTM net income has dropped by -$2.46 million (-34.20%).
- BRTX TTM net income is now -2381.30% below its all-time high of -$388.80 thousand, reached on September 30, 2010.
Performance
BRTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
BRTX Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +21.2% | -122.9% | -34.2% |
3 y3 years | +7.6% | +94.7% | +78.2% |
5 y5 years | +16.8% | +94.7% | +78.2% |
BRTX Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +76.5% | -122.9% | +94.7% | -154.7% | +78.2% |
5 y | 5-year | at high | +76.5% | -122.9% | +94.7% | -154.7% | +78.2% |
alltime | all time | -360.2% | +76.5% | -122.9% | +94.7% | -2381.3% | +78.2% |
BioRestorative Therapies Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$1.09 M(-72.9%) | -$9.65 M(+154.7%) |
Jun 2024 | - | -$4.03 M(+81.2%) | -$3.79 M(-30.7%) |
Mar 2024 | - | -$2.22 M(-3.5%) | -$5.47 M(-47.5%) |
Dec 2023 | -$10.42 M(-21.2%) | -$2.30 M(-148.3%) | -$10.42 M(+44.9%) |
Sep 2023 | - | $4.77 M(-183.5%) | -$7.19 M(-56.7%) |
Jun 2023 | - | -$5.71 M(-20.4%) | -$16.61 M(+6.6%) |
Mar 2023 | - | -$7.17 M(-875.5%) | -$15.58 M(+17.8%) |
Dec 2022 | -$13.22 M(-70.2%) | $924.90 K(-119.9%) | -$13.22 M(-61.7%) |
Sep 2022 | - | -$4.66 M(-0.4%) | -$34.55 M(+1.4%) |
Jun 2022 | - | -$4.68 M(-2.9%) | -$34.08 M(+1.8%) |
Mar 2022 | - | -$4.82 M(-76.4%) | -$33.47 M(-24.5%) |
Dec 2021 | -$44.30 M(+293.0%) | -$20.40 M(+387.6%) | -$44.30 M(+49.4%) |
Sep 2021 | - | -$4.18 M(+3.0%) | -$29.66 M(+12.7%) |
Jun 2021 | - | -$4.06 M(-74.0%) | -$26.31 M(+35.8%) |
Mar 2021 | - | -$15.65 M(+171.7%) | -$19.38 M(+71.9%) |
Dec 2020 | -$11.27 M(-23.0%) | -$5.76 M(+588.9%) | -$11.27 M(+59.6%) |
Sep 2020 | - | -$836.30 K(-129.1%) | -$7.06 M(-37.4%) |
Jun 2020 | - | $2.88 M(-138.1%) | -$11.28 M(-38.4%) |
Mar 2020 | - | -$7.55 M(+387.0%) | -$18.32 M(+25.0%) |
Dec 2019 | -$14.65 M(+17.0%) | -$1.55 M(-69.3%) | -$14.65 M(-12.1%) |
Sep 2019 | - | -$5.06 M(+21.6%) | -$16.67 M(+14.7%) |
Jun 2019 | - | -$4.16 M(+7.1%) | -$14.54 M(+4.6%) |
Mar 2019 | - | -$3.88 M(+8.8%) | -$13.89 M(+11.0%) |
Dec 2018 | -$12.52 M(+32.5%) | -$3.57 M(+22.1%) | -$12.52 M(+15.8%) |
Sep 2018 | - | -$2.93 M(-16.8%) | -$10.81 M(+8.8%) |
Jun 2018 | - | -$3.51 M(+40.1%) | -$9.93 M(+8.4%) |
Mar 2018 | - | -$2.51 M(+34.9%) | -$9.17 M(-2.9%) |
Dec 2017 | -$9.44 M | -$1.86 M(-9.4%) | -$9.44 M(-2.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2017 | - | -$2.05 M(-25.3%) | -$9.64 M(+2.3%) |
Jun 2017 | - | -$2.75 M(-1.4%) | -$9.42 M(+5.5%) |
Mar 2017 | - | -$2.79 M(+35.4%) | -$8.93 M(+3.5%) |
Dec 2016 | -$8.64 M(+9.0%) | -$2.06 M(+12.1%) | -$8.64 M(-11.0%) |
Sep 2016 | - | -$1.83 M(-18.8%) | -$9.70 M(+2.2%) |
Jun 2016 | - | -$2.26 M(-9.2%) | -$9.49 M(+9.7%) |
Mar 2016 | - | -$2.49 M(-20.3%) | -$8.65 M(+9.2%) |
Dec 2015 | -$7.92 M(+41.8%) | -$3.12 M(+92.1%) | -$7.92 M(+26.0%) |
Sep 2015 | - | -$1.62 M(+14.3%) | -$6.29 M(+9.1%) |
Jun 2015 | - | -$1.42 M(-19.3%) | -$5.77 M(+1.5%) |
Mar 2015 | - | -$1.76 M(+18.6%) | -$5.68 M(+1.6%) |
Dec 2014 | -$5.59 M(-2.8%) | -$1.48 M(+34.9%) | -$5.59 M(-2.6%) |
Sep 2014 | - | -$1.10 M(-17.4%) | -$5.73 M(-3.4%) |
Jun 2014 | - | -$1.33 M(-20.2%) | -$5.94 M(+1.4%) |
Mar 2014 | - | -$1.67 M(+2.4%) | -$5.85 M(+1.8%) |
Dec 2013 | -$5.75 M(-12.0%) | -$1.63 M(+25.2%) | -$5.75 M(-4.8%) |
Sep 2013 | - | -$1.30 M(+4.1%) | -$6.04 M(-2.8%) |
Jun 2013 | - | -$1.25 M(-20.1%) | -$6.21 M(-6.0%) |
Mar 2013 | - | -$1.57 M(-18.4%) | -$6.61 M(+1.1%) |
Dec 2012 | -$6.54 M(+60.5%) | -$1.92 M(+29.9%) | -$6.54 M(+21.9%) |
Sep 2012 | - | -$1.48 M(-10.3%) | -$5.36 M(+9.5%) |
Jun 2012 | - | -$1.65 M(+10.2%) | -$4.90 M(+9.9%) |
Mar 2012 | - | -$1.49 M(+101.2%) | -$4.46 M(+9.4%) |
Dec 2011 | -$4.07 M(+80.0%) | -$742.60 K(-26.7%) | -$4.07 M(-10.3%) |
Sep 2011 | - | -$1.01 M(-15.9%) | -$4.54 M(+15.9%) |
Jun 2011 | - | -$1.20 M(+8.2%) | -$3.92 M(+44.4%) |
Mar 2011 | - | -$1.11 M(-8.2%) | -$2.71 M(+69.5%) |
Dec 2010 | -$2.26 M | -$1.21 M(+211.8%) | -$1.60 M(+311.8%) |
Sep 2010 | - | -$388.80 K | -$388.80 K |
FAQ
- What is BioRestorative Therapies annual net profit?
- What is the all time high annual net income for BioRestorative Therapies?
- What is BioRestorative Therapies annual net income year-on-year change?
- What is BioRestorative Therapies quarterly net profit?
- What is the all time high quarterly net income for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly net income year-on-year change?
- What is BioRestorative Therapies TTM net profit?
- What is the all time high TTM net income for BioRestorative Therapies?
- What is BioRestorative Therapies TTM net income year-on-year change?
What is BioRestorative Therapies annual net profit?
The current annual net income of BRTX is -$10.42 M
What is the all time high annual net income for BioRestorative Therapies?
BioRestorative Therapies all-time high annual net profit is -$2.26 M
What is BioRestorative Therapies annual net income year-on-year change?
Over the past year, BRTX annual net profit has changed by +$2.80 M (+21.21%)
What is BioRestorative Therapies quarterly net profit?
The current quarterly net income of BRTX is -$1.09 M
What is the all time high quarterly net income for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly net profit is $4.77 M
What is BioRestorative Therapies quarterly net income year-on-year change?
Over the past year, BRTX quarterly net profit has changed by -$5.86 M (-122.89%)
What is BioRestorative Therapies TTM net profit?
The current TTM net income of BRTX is -$9.65 M
What is the all time high TTM net income for BioRestorative Therapies?
BioRestorative Therapies all-time high TTM net profit is -$388.80 K
What is BioRestorative Therapies TTM net income year-on-year change?
Over the past year, BRTX TTM net profit has changed by -$2.46 M (-34.20%)